Search results for "Organs"

showing 10 items of 2730 documents

Age and gender difference in non-drafting ultra-endurance cycling performance - the 'Swiss Cycling Marathon'.

2013

Abstract Background In recent years, there was an increased interest in investigating the gender difference in performance and the age of peak performance in ultra-endurance performances such as ultra-triathlon, ultra-running, and ultra-swimming, but not in ultra-cycling. The aim of the present study was to analyze the gender difference in ultra-cycling performance and the age of peak ultra-cycling performance in the 720-km ‘Swiss Cycling Marathon’, the largest European qualifier for the ‘Race Across America’. Methods Changes in the cycling speed and age of 985 finishers including 38 women and 947 men competing in the Swiss Cycling Marathon from 2001 to 2012 covering a distance of 720 km wi…

11035 Institute of General PracticeGerontologyFuture studies[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Physiology610 Medicine & healthAge and gender03 medical and health sciences2732 Orthopedics and Sports Medicine2737 Physiology (medical)0302 clinical medicineAthletePhysiology (medical)[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicineOrthopedics and Sports MedicineWomen030212 general & internal medicineUltra enduranceSportbusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]ResearchMen1314 Physiology030229 sport sciencesHuman physiologyGender gapbusinessCyclingDemographyExtreme physiologymedicine
researchProduct

Participation and performance trends in ultra-endurance running races under extreme conditions - 'Spartathlon' versus 'Badwater'

2013

Abstract Background The aim of the present study was to compare the trends in participation, performance and age of finishers in ‘Badwater’ and ‘Spartathlon’ as two of the toughest ultramarathons in the world of more than 200 km of distance. Methods Running speed and age of male and female finishers in Badwater and Spartathlon were analyzed from 2000 to 2012. Age of peak performance and sex difference in running speed were investigated during the studied period. Results The number of female and male finishes increased in Badwater and Spartathlon. Women accounted on average for 21.5% ± 6.9% in Badwater and 10.8% ± 2.3% in Spartathlon. There was a significant increase in female participation …

11035 Institute of General PracticeGerontologyPhysiology[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]610 Medicine & healthRunning03 medical and health sciences2732 Orthopedics and Sports Medicine2737 Physiology (medical)0302 clinical medicineAnimal scienceAgePhysiology (medical)Sex differences[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicineOrthopedics and Sports MedicineUltra enduranceExtreme conditions[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryResearch1314 Physiology030229 sport sciencesHuman physiologyUltra-endurancebusiness030217 neurology & neurosurgery
researchProduct

The age of peak performance in Ironman triathlon: a cross-sectional and longitudinal data analysis.

2013

Abstract Background The aims of the present study were, firstly, to investigate in a cross-sectional analysis the age of peak Ironman performance within one calendar year in all qualifiers for Ironman Hawaii and Ironman Hawaii; secondly, to determine in a longitudinal analysis on a qualifier for Ironman Hawaii whether the age of peak Ironman performance and Ironman performance itself change across years; and thirdly, to determine the gender difference in performance. Methods In a cross-sectional analysis, the age of the top ten finishers for all qualifier races for Ironman Hawaii and Ironman Hawaii was determined in 2010. For a longitudinal analysis, the age and the performance of the annua…

11035 Institute of General PracticeGerontologymedicine.medical_specialtyVeterinary medicineSports medicine[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]PhysiologyLongitudinal dataMEDLINE610 Medicine & healthEnduranceRunning03 medical and health sciences2732 Orthopedics and Sports Medicine2737 Physiology (medical)0302 clinical medicine5. Gender equalityPhysiology (medical)medicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Orthopedics and Sports MedicineSwimming[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryResearchCycling1314 Physiology030229 sport sciencesHuman physiologybusiness030217 neurology & neurosurgery
researchProduct

Master runners dominate 24-h ultramarathons worldwide—a retrospective data analysis from 1998 to 2011

2013

Abstract Background The aims of the present study were to examine (a) participation and performance trends and (b) the age of peak running performance in master athletes competing in 24-h ultra-marathons held worldwide between 1998 and 2011. Methods Changes in both running speed and the age of peak running speed in 24-h master ultra-marathoners (39,664 finishers, including 8,013 women and 31,651 men) were analyzed. Results The number of 24-h ultra-marathoners increased for both women and men across years (P < 0.01). The age of the annual fastest woman decreased from 48 years in 1998 to 35 years in 2011. The age of peaking running speed remained unchanged across time at 42.5 ± 5.2 years f…

11035 Institute of General PracticeVeterinary medicinePhysiology[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]610 Medicine & healthRunning speedRetrospective data03 medical and health sciences0302 clinical medicine2732 Orthopedics and Sports Medicine2737 Physiology (medical)Age groupsPhysiology (medical)[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicineGender differenceOrthopedics and Sports Medicine030212 general & internal medicinebusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Research030229 sport sciencesHuman physiology1314 PhysiologyAge of peak performanceMale agebusinessDemographyExtreme Physiology & Medicine
researchProduct

Age-related changes in ultra-triathlon performances

2012

International audience; BackgroundThe age-related decline in performance has been investigated in swimmers, runners and triathletes. No study has investigated the age-related performance decline in ultra-triathletes. The purpose of this study was to analyse the age-related declines in swimming, cycling, running and overall race time for both Triple Iron ultra-triathlon (11.4-km swimming, 540-km cycling and 126.6-km running) and Deca Iron ultra-triathlon (38-km swimming, 1,800-km cycling and 420-km running).MethodsThe age and performances of 423 male Triple Iron ultra-triathletes and 119 male Deca Iron ultra-triathletes were analysed from 1992 to 2010 using regression analyses and ANOVA.Resu…

11035 Institute of General PracticeVeterinary medicine[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Physiology610 Medicine & healthRunning03 medical and health sciences0302 clinical medicineAnimal science2732 Orthopedics and Sports Medicine2737 Physiology (medical)Physiology (medical)Age related[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicineOrthopedics and Sports MedicineUltra enduranceSwimmingbusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Researchtechnology industry and agricultureMean ageCycling030229 sport sciencesHuman physiology1314 PhysiologyUltra-enduranceCyclingbusinesshuman activities030217 neurology & neurosurgeryDeca-
researchProduct

Analysis of swimming performance in FINA World Cup long-distance open water races

2014

International audience; BACKGROUND: Age and peak performance in ultra-endurance athletes have been mainly investigated in long-distance runners and triathletes, but not for long-distance swimmers. The present study investigated the age and swimming performance of elite ultra-distance swimmers competing in the 5-, 10- and 25-km Fédération Internationale de Natation (FINA) World Cup swimming events. METHODS: The associations of age and swimming speed in elite male and female swimmers competing in World Cup events of 5-, 10- and 25-km events from 2000 to 2012 were analysed using single and multi-level regression analyses. RESULTS: During the studied period, the swimming speed of the annual top…

11035 Institute of General PracticeVeterinary medicine[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Physiologybusiness.industryResearchSwim610 Medicine & health1314 PhysiologySpeedHuman physiologyAge of peak performanceSwimming speed2732 Orthopedics and Sports Medicine2737 Physiology (medical)Open waterPhysiology (medical)[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicinePeak performanceOrthopedics and Sports MedicinebusinessDemographyExtreme Physiology & Medicine
researchProduct

Changes in transition times in ‘Ironman Hawaii’ between 1998 and 2013

2014

International audience; BackgroundRecent findings showed that elite Ironman triathletes competing in ‘Ironman Hawaii’ improved both split and overall race times. The present study investigated whether elite athletes also improved in transition time (i.e. time needed between disciplines for changing clothes and equipment).MethodsChanges in split times, overall race times and transition times (i.e. expressed in absolute and relative terms) in the annual fastest competing in ‘Ironman Hawaii’ were investigated using linear, non-linear and multi-level regression analyses. To detect a potential difference in transition times between different race distances, we compared transition times in ‘Ironm…

11035 Institute of General Practice[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Physical Therapy Sports Therapy and Rehabilitation610 Medicine & healthRunningEndurance2732 Orthopedics and Sports Medicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]MedicineOrthopedics and Sports MedicineElite athletes3612 Physical Therapy Sports Therapy and RehabilitationSwimmingbusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Rehabilitation[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieCyclingTransition timeSex difference2742 RehabilitationPotential difference[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessDemographyResearch Article
researchProduct

Problématiques de la nutrition en ophtalmologie – application à la dégénérescence maculaire liée à l’âge

2014

Nutrition in ophthalmology – clinical application to age-related macular degeneration «Let food be your medicine.» This contribution from Hippocrates is still timely addressed, especially in the field of ophthalmology. Observational epidemiology reports close associations between food habits and the risk or prevention of several ocular pathologies such as cataract or Age-related Macular Degeneration (AMD). Anti-oxidant vitamins, minerals and lipids are the nutrients that have been the most widely studied. Interventional epidemiology and experimental works partially corroborated these findings. Unexpectedly, the benefit of long chain omega 3 polyunsaturated fatty acids in the prevention of l…

2. Zero hungerretinaGeneral Veterinarygenetic structuresPhilosophyage related macular degenerationfood[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionagingnutrition ; alimentation ; rétine ; lipides ; caroténoïdes ; prévention ; vieillissement ; dégénérescence maculaire liée à l’âge.eye diseasescarotenoid3. Good health[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionprevention ; food ; aging ; age-related macular degeneration. ; diet ; carotenoids ; lipids ; retinaprevention[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organslipid[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organssense organs[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansdietHumanities[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Widening use of dexamethasone implant for the treatment of macular edema

2017

Vincenza Bonfiglio, Michele Reibaldi, Matteo Fallico, Andrea Russo, Alessandra Pizzo, Stefano Fichera, Carlo Rapisarda, Iacopo Macchi, Teresio Avitabile, Antonio Longo Department of Ophthalmology, University of Catania, Catania, Italy Abstract: Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolymer to release the active ingredient within the vitreous chamber for up to 6 months after an intravitreal injection, allowing a prolonged interval of effica…

3003intravitrealgenetic structuresimplantmedicine.medical_treatmentPharmaceutical ScienceVitrectomyReviewDrug Implantcorticosteroids0302 clinical medicineGlucocorticoidCentral retinal vein occlusionDrug DiscoveryDelayed-Action PreparationCorticosteroidRandomized Controlled Trials as TopicDrug ImplantsCorticosteroids; Dexamethasone; Implant; Intravitreal; Macular edema; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical ScienceDiabetic retinopathyIntravitreal InjectionsUveitismedicine.drugHumanmedicine.medical_specialtydexamethasone03 medical and health sciencesOphthalmologymedicineHumansMacular edemaGlucocorticoidsDexamethasonePharmacologyMacular edemaDiabetic Retinopathybusiness.industryIntravitreal InjectionDrug Discovery3003 Pharmaceutical Sciencelcsh:RM1-950Macular degenerationmedicine.diseaseeye diseasesSurgerylcsh:Therapeutics. PharmacologyDelayed-Action Preparations030221 ophthalmology & optometryBranch retinal vein occlusionsense organsbusiness030217 neurology & neurosurgeryDrug Design, Development and Therapy
researchProduct

Multicenter clinical trial of ultrasonic circular cyclo coagulation in patients with open-angle glaucoma: One year results

2014

International audience; Purpose: To evaluate the efficacy and safety of the Ultrasonic Circular Cyclo Coagulation (UC3) procedure with one year of follow-up. Methods: Prospective non comparative interventional clinical study performed in 9 French glaucoma centers. Fifty-two eyes of 52 patients with open-angle glaucoma, intraocular pressure (IOP) > 21 mmHg, an average of 1.7 failed previous surgeries and an average of 3.7 hypotensive medications were insonified with a therapy probe comprising 6 piezoelectric transducers. The 6 transducers were activated, 24 patients (group 1) were treated with a 4 seconds exposure time for each shot and 28 patients (group 2) with a 6 seconds exposure time. C…

427 aqueous[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologygenetic structures455 ciliary body[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organseye diseases[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct